A Prospective, Randomised, Placebo Controlled Study to Evaluate the Impact of GLUBLOC™ on postprandial blood glucose levels in healthy individuals post carbohydrate rich meal intake. - NI

My Pura Vida Wellness Pvt Ltd0 个研究点目标入组 107 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Aged between 18 to 60 years
•BMI between 18.5 and 29.9 kg per m2
•Fasting blood glucose greater than 70 mg per dl and less than or equal to 99 mg per dl

•History of hypersensitivity to any of the investigational product, excipients, or Any known food allergies.
•Pre-existing medical condition or taking medication known to affect glucose regulation or influence digestion and absorption of nutrients
•History of diabetes mellitus (type I or II) or they used antihyperglycemic drugs or insulin to treat diabetes or related conditions
•Used steroids, protease inhibitors or antipsychotic medicines as these drugs are known to impact glucose metabolism and body fat distribution.
•Subjects with the history of uncontrolled hypertension or hyperthyroidism.
•History of alcoholism
•Subjects with psychiatric or neurological disability or mental health disorder
•Subjects with serious health conditions such as cardiac disease, renal dysfunction, and cancers.
•Subjects who donot have basic understanding of English language, which include speaking or writing in English.
•Female subjects who are pregnant or had planned for pregnancy in the following months or were breast feeding.
•Subjects who refuse to sign informed consent.
•According to the investigators opinion, participants who are deemed unable to comply with the test requirements or otherwise deemed unsuitable.

发起方

My Pura Vida Wellness Pvt Ltd